Caliber Wealth Management LLC KS bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 7,698 shares of the company's stock, valued at approximately $2,660,000.
Several other hedge funds also recently made changes to their positions in the stock. Avantax Advisory Services Inc. lifted its stake in HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after purchasing an additional 32 shares during the last quarter. Congress Wealth Management LLC DE raised its position in HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the last quarter. Catalyst Financial Partners LLC raised its position in shares of HCA Healthcare by 4.3% in the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock worth $301,000 after acquiring an additional 36 shares in the last quarter. Perigon Wealth Management LLC raised its position in shares of HCA Healthcare by 2.3% in the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after acquiring an additional 40 shares in the last quarter. Finally, Barden Capital Management Inc. increased its position in HCA Healthcare by 1.4% during the 1st quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after buying an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Stock Down 2.1%
Shares of HCA Healthcare stock traded down $7.22 during trading on Friday, reaching $334.26. The company's stock had a trading volume of 3,175,863 shares, compared to its average volume of 1,334,458. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The company has a market cap of $80.41 billion, a price-to-earnings ratio of 14.05, a P/E/G ratio of 1.17 and a beta of 1.47. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a 50-day simple moving average of $373.81 and a two-hundred day simple moving average of $345.92.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 EPS. The firm's revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. HCA Healthcare's payout ratio is currently 12.81%.
Insider Buying and Selling at HCA Healthcare
In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.30% of the company's stock.
Wall Street Analysts Forecast Growth
HCA has been the subject of a number of research analyst reports. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price for the company. in a report on Wednesday, July 16th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $404.00 target price (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Truist Financial upped their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Finally, Robert W. Baird restated a "neutral" rating and set a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Eight equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $399.46.
Read Our Latest Stock Report on HCA
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.